CTSS in the tumor microenvironment links immune escape and immunotherapy sensitivity in kidney renal clear cell carcinoma

CTSS in the tumor microenvironment links immune escape and immunotherapy sensitivity in kidney renal clear cell carcinoma

Abstract The tumor microenvironment (TME) of kidney renal clear cell carcinoma (KIRC) exhibits complex dynamics among immune, stromal, and malignant cells that drive immune escape (IE) mechanisms and influence clinical outcomes. Through single-cell RNA sequencing and high-dimensional weighted gene c...

Full description

Saved in:
Bibliographic Details
Main Authors: Hanjing Zhou, Jun Ying, Xuchun Xu, Jian Huang
Format: Article
Language:English
Published: Springer 2025-07-01
Series:Discover Oncology
Subjects:
KIRC
CTSS
Immune escape
Machine learning
Immunotherapy
Online Access:https://doi.org/10.1007/s12672-025-03267-8
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract The tumor microenvironment (TME) of kidney renal clear cell carcinoma (KIRC) exhibits complex dynamics among immune, stromal, and malignant cells that drive immune escape (IE) mechanisms and influence clinical outcomes. Through single-cell RNA sequencing and high-dimensional weighted gene co-expression network analysis (hdWGCNA), we identified a crucial IE-related gene module most strongly associated with KIRC progression. Partitioning Around Medoids (PAM) clustering delineated two distinct IE patterns, with pattern one demonstrating prolonged patient survival. Employing advanced machine learning (ML) algorithms, we identified Cathepsin S (CTSS) as the most pivotal tumor suppressor, with elevated CTSS expression consistently predicting improved survival across multiple independent cohorts. Functional analyses revealed significant enrichment of CTSS in immune-regulatory pathways, including B/T cell activation and inflammatory activity. Mutation profiling uncovered distinct genomic alterations in 5q35.3 among CTSS-high tumors, while drug response prediction identified eight potential therapeutic agents (e.g., Navitoclax, Ibrutinib) exhibiting enhanced efficacy in these patients. Notably, CTSS expression strongly correlated with immune cell infiltration and established immunotherapy biomarkers, supporting its dual role as both a prognostic indicator and predictor of immune response. This study provides mechanistic insights into IE in KIRC and positions CTSS as a promising biomarker and therapeutic target for precision immunotherapy.
ISSN:2730-6011

Similar Items